A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres.

DNA double-strand breaks (DSBs), extra-chromosomal telomeric repeats (ECTRs), promyelocytic leukemia (PML) bodies alternative lengthening of telomeres (ALT), DNA polymerase λ microhomology-mediated strand transfer (MMST) activity telomere dysfunction-induced foci (TIFs), telomere stress

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Feb 2021
Historique:
received: 20 01 2021
revised: 13 02 2021
accepted: 23 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 5 5 2021
Statut: epublish

Résumé

Telomerase negative cancer cell types use the Alternative Lengthening of Telomeres (ALT) pathway to elongate telomeres ends. Here, we show that silencing human DNA polymerase (Pol λ) in ALT cells represses ALT activity and induces telomeric stress. In addition, replication stress in the absence of Pol λ, strongly affects the survival of ALT cells. In vitro, Pol λ can promote annealing of even a single G-rich telomeric repeat to its complementary strand and use it to prime DNA synthesis. The noncoding telomeric repeat containing RNA TERRA and replication protein A negatively regulate this activity, while the Protection of Telomeres protein 1 (POT1)/TPP1 heterodimer stimulates Pol λ. Pol λ associates with telomeres and colocalizes with TPP1 in cells. In summary, our data suggest a role of Pol λ in the maintenance of telomeres by the ALT mechanism.

Identifiants

pubmed: 33673424
pii: ijms22052365
doi: 10.3390/ijms22052365
pmc: PMC7956399
pii:
doi:

Substances chimiques

ACD protein, human 0
Multiprotein Complexes 0
POT1 protein, human 0
Replication Protein A 0
Shelterin Complex 0
Telomere-Binding Proteins 0
DNA polymerase beta2 EC 2.7.7.-
DNA Polymerase beta EC 2.7.7.7
Serine Proteases EC 3.4.-
Aminopeptidases EC 3.4.11.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG20762
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : MFAG2016 18811
Organisme : Fondazione Italiana per la Ricerca sul Cancro
ID : 24263
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : Start-up Grant 12710

Références

Nat Cell Biol. 2012 Mar 18;14(4):355-65
pubmed: 22426077
Cell Rep. 2016 Jun 7;15(10):2170-2184
pubmed: 27239034
Nature. 2012 Aug 23;488(7412):540-4
pubmed: 22763445
FEBS Lett. 2004 Jun 1;567(1):142-6
pubmed: 15165907
Science. 2012 May 4;336(6081):593-7
pubmed: 22556254
Cell Rep. 2016 Nov 1;17(6):1646-1656
pubmed: 27806302
Cancers (Basel). 2018 May 30;10(6):
pubmed: 29848986
Chem Res Toxicol. 2017 Nov 20;30(11):1936-1941
pubmed: 28841305
Nature. 2016 Nov 3;539(7627):54-58
pubmed: 27760120
Sci Rep. 2016 Aug 31;6:32280
pubmed: 27578458
Science. 2015 Jan 16;347(6219):273-7
pubmed: 25593184
Nucleic Acids Res. 2013 Jan 7;41(1):229-41
pubmed: 23118481
Genes (Basel). 2019 Apr 24;10(4):
pubmed: 31022960
Mol Cell Biol. 2004 Nov;24(22):9948-57
pubmed: 15509797
J Neurooncol. 2019 May;142(3):435-444
pubmed: 30830680
Nat Struct Mol Biol. 2015 Nov;22(11):853-8
pubmed: 26581519
EMBO Rep. 2016 Dec;17(12):1731-1737
pubmed: 27760777
Cell Rep. 2019 Jan 22;26(4):955-968.e3
pubmed: 30673617
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Mol Biol. 2003 Apr 18;328(1):63-72
pubmed: 12683997
Nature. 2011 Mar 24;471(7339):532-6
pubmed: 21399625
Cell. 2009 Jul 10;138(1):90-103
pubmed: 19596237
Am J Pathol. 2011 Oct;179(4):1608-15
pubmed: 21888887
Nucleic Acids Res. 2006 Mar 06;34(5):1405-15
pubmed: 16522650
Nucleic Acids Res. 2012 Jul;40(12):5577-90
pubmed: 22373917
Nat Biotechnol. 2009 Dec;27(12):1181-5
pubmed: 19935656
DNA Repair (Amst). 2015 May;29:101-11
pubmed: 25687118
PLoS Genet. 2019 Feb 4;15(2):e1007925
pubmed: 30716077
Mol Cell Biol. 2009 Feb;29(3):703-13
pubmed: 19015236
Cell Rep. 2016 Nov 8;17(7):1858-1871
pubmed: 27829156
Nat Struct Mol Biol. 2015 Mar;22(3):230-7
pubmed: 25643323
BMC Cancer. 2019 Mar 14;19(1):232
pubmed: 30871494
Biochem Biophys Res Commun. 2014 Mar 7;445(2):363-8
pubmed: 24513288
Genes Dev. 2011 Oct 1;25(19):2041-56
pubmed: 21979917
Nucleus. 2012 May-Jun;3(3):263-75
pubmed: 22572954
Nucleic Acids Res. 2007;35(21):7267-78
pubmed: 17959650
Trends Genet. 2017 Dec;33(12):921-932
pubmed: 28969871
Nature. 2015 Feb 12;518(7538):254-7
pubmed: 25642960
J Biol Chem. 2005 Mar 18;280(11):10840-5
pubmed: 15657051
RNA Biol. 2015;12(9):938-41
pubmed: 26158306
Mol Cell. 2010 Nov 12;40(3):377-87
pubmed: 21070964
Lancet. 2003 Mar 8;361(9360):836-8
pubmed: 12642053
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Mol Cell Biol. 2002 Jul;22(13):4512-21
pubmed: 12052861
FEBS Lett. 2010 Sep 10;584(17):3800-11
pubmed: 20542034
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Crit Rev Biochem Mol Biol. 2017 Feb;52(1):57-73
pubmed: 27892716
Cell. 2014 Sep 25;159(1):108-121
pubmed: 25259924
DNA Repair (Amst). 2005 May 2;4(5):583-93
pubmed: 15811630

Auteurs

Elisa Mentegari (E)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Federica Bertoletti (F)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Miroslava Kissova (M)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Elisa Zucca (E)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Silvia Galli (S)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Giulia Tagliavini (G)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Anna Garbelli (A)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Antonio Maffia (A)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Silvia Bione (S)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Elena Ferrari (E)

Department of Molecular Mechanisms of Disease, University of Zürich-Irchel, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.

Fabrizio d'Adda di Fagagna (FDD)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.
IFOM-The FIRC Institute of Molecular Oncology, 20139 Milan, Italy.

Sofia Francia (S)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Simone Sabbioneda (S)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Liuh-Yow Chen (LY)

Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Frontiers in Genetics National Center of Competence in Research, Ecole Polytechnique Fédérale de Lausanne (EPFL), Station 19, CH-1015 Lausanne, Switzerland.

Joachim Lingner (J)

Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Frontiers in Genetics National Center of Competence in Research, Ecole Polytechnique Fédérale de Lausanne (EPFL), Station 19, CH-1015 Lausanne, Switzerland.

Valerie Bergoglio (V)

UMR1037 INSERM, Cancer Research Center of Toulouse, 2 Avenue Curien, 31037 Toulouse, France.

Jean-Sébastien Hoffmann (JS)

Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 avenue Irène-Joliot-Curie, 31059 Toulouse, France.

Ulrich Hübscher (U)

Department of Molecular Mechanisms of Disease, University of Zürich-Irchel, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.

Emmanuele Crespan (E)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Giovanni Maga (G)

Institute of Molecular Genetics IGM-CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, I-27100 Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH